Fulgent Genetics, Inc. (FLGT) shares rose 16.70 percent to $26.03 on Friday following the company's third-quarter revenue growth and a smaller net loss compared to the previous year.
Compared to $71.74 million in the same period last year, revenue for the quarter climbed to $84.07 million. In contrast to last year, when it reported a loss of $14.65 million, or $0.48 per share, the company reported a net loss of $6.61 million, or $0.21 per share.
Before closing at $25.63, up from a previous close of $22.31, the stock on the Nasdaq opened at $24.04 and fluctuated between $23.68 and $27.36 during the session. The trading volume went above the average of 215,000 shares, reaching around 396,000 shares.
Over the previous 52 weeks, the price of Fulgent Genetics' shares has fluctuated between $14.57 and $27.36.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.